PFBT
PCRX icon

Parkside Financial Bank & Trust’s Pacira BioSciences PCRX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28K Hold
90
– – ﹤0.01% 2142
2026
Q1 		$2.04K Sell
90
-495
-85% -$11K ﹤0.01% 2111
2025
Q4 		$15.1K Buy
585
+65
+13% +$1.55K ﹤0.01% 1396
2025
Q3 		$13.4K Buy
520
+24
+5% +$589 ﹤0.01% 1402
2025
Q2 		$11.9K Buy
496
+23
+5% +$580 ﹤0.01% 1433
2025
Q1 		$11.8K Buy
473
+455
+2,528% +$10.9K ﹤0.01% 1349
2024
Q4 		$340 Hold
18
– – ﹤0.01% 1950
2024
Q3 		$271 Buy
18
+13
+260% +$222 ﹤0.01% 1952
2024
Q2 		$144 Sell
5
-9
-64% -$256 ﹤0.01% 1986
2024
Q1 		$410 Hold
14
– – ﹤0.01% 1794
2023
Q4 		$473 Buy
+14
New +$410 ﹤0.01% 1762
2023
Q3 		– Sell
-46
Closed -$1.84K – 2095
2023
Q2 		$1.84K Sell
46
-123
-73% -$5.08K ﹤0.01% 1711
2023
Q1 		$6.9K Buy
169
+53
+46% +$2.11K ﹤0.01% 1237
2022
Q4 		$4.48K Buy
116
+17
+17% +$827 ﹤0.01% 1364
2022
Q3 		$5K Sell
99
-36
-27% -$2K ﹤0.01% 1232
2022
Q2 		$8K Buy
135
+27
+25% +$1.77K ﹤0.01% 1075
2022
Q1 		$8K Sell
108
-43
-28% -$2.87K ﹤0.01% 1116
2021
Q4 		$9K Buy
151
+30
+25% +$1.65K ﹤0.01% 1070
2021
Q3 		$7K Buy
121
+4
+3% +$231 ﹤0.01% 1104
2021
Q2 		$7K Sell
117
-10
-8% -$633 ﹤0.01% 1119
2021
Q1 		$9K Hold
127
– – ﹤0.01% 979
2020
Q4 		$8K Buy
127
+93
+274% +$5.45K ﹤0.01% 952
2020
Q3 		$2K Buy
34
+6
+21% +$349 ﹤0.01% 1202
2020
Q2 		$1K Buy
28
+18
+180% +$752 ﹤0.01% 1360
2020
Q1 		$0 Sell
10
-39
-80% -$1.62K ﹤0.01% 1597
2019
Q4 		$2K Buy
+49
New +$2.08K ﹤0.01% 1218
2016
Q2 		– Sell
-122
Closed -$6K – 1095
2016
Q1 		$6K Buy
+122
New +$7.14K ﹤0.01% 750

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's PCRX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 90 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Parkside Financial Bank & Trust first reported a position in PCRX in Q1 2016 and has held it in 27 quarters since. The position peaked at $15.1K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Parkside Financial Bank & Trust held 90 shares of Pacira BioSciences worth $2.28K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2142 holding.
  • Parkside Financial Bank & Trust first reported a position in Pacira BioSciences in Q1 2016 and has held it in 27 quarters since.
  • Parkside Financial Bank & Trust's Pacira BioSciences position peaked at $15.1K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.